Liver and Spleen Stiffness Measurements for Assessment of Portal Hypertension Severity in Patients with Budd Chiari Syndrome

الملخص EN

Aims.

Budd-Chiari Syndrome (BCS) is a rare vascular disease of the liver caused by the obstruction of the hepatic venous outflow located from the small hepatic venules up to the entrance of the inferior vena cava (IVC) into the right atrium.

Current prognostic indexes are suboptimal for an individual prognostic assessment and subsequent management of patients with BCS.

Liver (LSM) and spleen (SSM) stiffness measurements are widely validated prognostic tools in hepatology, but the evidence in patients with BCS is limited.

This paper describes LSM and SSM in patients with BCS and their correlation with clinical, biochemical, and ultrasound findings from the same patients.

Methods.

We investigated a case series of seven patients with BCS diagnosis and available LSM and SSM evaluated by transient elastography (TE).

Biochemical, imaging, and endoscopic findings nearest to the TE evaluation were recorded.

Clinical outcomes and BCS evolution were described for each patient.

When available, repeated TE assessments were also recorded.

Results.

Patients with acute nonfulminant manifestation of BCS presented near-the-upper-limit values (75 kPa) of LSM and SSM, which often persist until the placement of a transjugular intrahepatic portosystemic shunt (TIPS).

On the other hand, TE values were markedly lower in patients with compensated BCS.

In some patients with repeated TE measurement years after TIPS placement, LSM had decreased to values of <10 kPa years.

SSM changes in these patients were, however, less evident.

Conclusions.

Extremely elevated values of LSM and SSM are suggestive of BCS.

The evaluation of both LSM and SSM by TE could help clinicians in the initial evaluation, risk stratification, and therapy response monitoring of patients with BCS.